The US government didn’t legalize marijuana: 4 cannabis misconceptions explained
The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. …
Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
By Puyaan Singh and Christy Santhosh April 30 (Reuters) – Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public …
It Ain’t Just Bud: Black-Owned Brands That Contribute To The Cannabis Industry
How big is the Black-owned cannabis market? The legal cannabis industry generates billions of dollars annually—reaching an estimated $40 billion in 2024—but suffers from a significant imbalance in …
How MSO TerrAscend is leading the cannabis industry forward
TerrAscend will leverage federal rescheduling of medical cannabis to drive growth, shape policy with a focus on compliance and expansion.
Colorado to crack down on “highly problematic,” contaminated marijuana products
State regulators are warning bad actors who are bringing hemp‑derived, often chemically-altered products into the state’s legal marijuana system that there will be consequences.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Marijuana Companies Eye Investment Boom After Trump Admin Reschedules Drug
Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise nearly $20 million in private funding.
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.
This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now
The cannabis industry has spent years navigating regulatory uncertainty, limiting the growth and profitability of marijuana companies despite strong demand. However, a fresh policy push from President …
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth (NASDAQ: CGC) is a Canadian marijuana company. When it first came public marijuana was a hot sector, but investor enthusiasm has waned. The stock has since declined to the point where it …
AKAN stock leaves cannabis peers in the smoke with a stunning 1,700% rally in April — what’s fueling the run?
AKAN is also on track for its best week ever with gains of 300% so far. ・Investor sentiment across cannabis stocks improved after the U.S. Justice Department moved state-regulated marijuana toward …
CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned
SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 /CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding …
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Patches
Detailed price information for Cbd Life Sciences Inc (CBDL) from The Globe and Mail including charting and trades.
Roth Capital Highlights Discontinued CBD Products Weighing on FitLife Brands, Inc. (FTLF)
We recently compiled a list of the 10 Best Beaten Down Stocks to Invest in According to Analysts. FitLife Brands, Inc. is one of the best 52-week low stocks on our list. TheFly reported on April 6 …
Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program
Vantage Hemp Co. (“Vantage” or “the Company”), a cannabinoid manufacturer focused on pharmaceutical-grade production, announces active engagement with multiple Accountable Care Organizations (ACOs) …
Recent Comments